| Year |
Citation |
Score |
| 2021 |
Grotell M, den Hollander B, Jalkanen A, Törrönen E, Ihalainen J, de Miguel E, Dudek M, Kettunen MI, Hyytiä P, Forsberg MM, Kankuri E, Korpi ER. Alcohol Co-Administration Changes Mephedrone-Induced Alterations of Neuronal Activity. Frontiers in Pharmacology. 12: 679759. PMID 33995109 DOI: 10.3389/fphar.2021.679759 |
0.452 |
|
| 2015 |
den Hollander B, Sundström M, Pelander A, Siltanen A, Ojanperä I, Mervaala E, Korpi ER, Kankuri E. Mitochondrial respiratory dysfunction due to the conversion of substituted cathinones to methylbenzamides in SH-SY5Y cells. Scientific Reports. 5: 14924. PMID 26462443 DOI: 10.1038/srep14924 |
0.605 |
|
| 2015 |
Korpi ER, den Hollander B, Farooq U, Vashchinkina E, Rajkumar R, Nutt DJ, Hyytiä P, Dawe GS. Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse. Pharmacological Reviews. 67: 872-1004. PMID 26403687 DOI: 10.1124/Pr.115.010967 |
0.676 |
|
| 2014 |
den Hollander B, Dudek M, Ojanperä I, Kankuri E, Hyytiä P, Korpi ER. Manganese-enhanced magnetic resonance imaging reveals differential long-term neuroadaptation after methamphetamine and the substituted cathinone 4-methylmethcathinone (mephedrone). The International Journal of Neuropsychopharmacology. 18. PMID 25522432 DOI: 10.1093/ijnp/pyu106 |
0.654 |
|
| 2014 |
den Hollander B, Sundström M, Pelander A, Ojanperä I, Mervaala E, Korpi ER, Kankuri E. Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone. Toxicological Sciences : An Official Journal of the Society of Toxicology. 141: 120-31. PMID 24913801 DOI: 10.1093/toxsci/kfu108 |
0.555 |
|
| 2013 |
Vashchinkina E, Manner AK, Vekovischeva O, den Hollander B, Uusi-Oukari M, Aitta-Aho T, Korpi ER. Neurosteroid Agonist at GABAA receptor induces persistent neuroplasticity in VTA dopamine neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 727-37. PMID 24077066 DOI: 10.1038/npp.2013.258 |
0.646 |
|
| 2012 |
den Hollander B, Rozov S, Linden AM, Uusi-Oukari M, Ojanperä I, Korpi ER. Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone. Pharmacology, Biochemistry, and Behavior. 103: 501-9. PMID 23099177 DOI: 10.1016/j.pbb.2012.10.006 |
0.724 |
|
| 2011 |
Tacke U, den Hollander B, Simojoki K, Korpi ER, Pihlainen K, Alho H. [Designer drugs in Finland]. Duodecim; Laaketieteellinen Aikakauskirja. 127: 2027-36. PMID 22073534 |
0.592 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2011 |
Wiskerke J, Schetters D, van Es IE, van Mourik Y, den Hollander BR, Schoffelmeer AN, Pattij T. μ-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 262-72. PMID 21209211 DOI: 10.1523/Jneurosci.4794-10.2011 |
0.264 |
|
| 2012 |
Klomp A, den Hollander B, de Bruin K, Booij J, Reneman L. The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals. Plos One. 7: e47524. PMID 23115651 DOI: 10.1371/Journal.Pone.0047524 |
0.216 |
|
| 2012 |
den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L. Preliminary evidence of hippocampal damage in chronic users of ecstasy. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 83-5. PMID 21444322 DOI: 10.1136/Jnnp.2010.228387 |
0.206 |
|
| 2016 |
Park BY, Grisham RN, den Hollander B, Thapi D, Berman T, de Stanchina E, Zhou Q, Iyer G, Aghajanian C, Spriggs DR. Tumor Inhibition by Enzalutamide in a Xenograft Model of Ovarian Cancer. Cancer Investigation. 1-4. PMID 27824515 DOI: 10.1080/07357907.2016.1242598 |
0.021 |
|
| Hide low-probability matches. |